Foghorn Therapeutics Inc

Company Snapshot
500 Technology Square
Cambridge, MA 02139
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 161
https://www.foghorntx.com
Please select from the dropdown
  1. Executive Compensation
  2. > Foghorn Therapeutics Inc
Company Financials

2019
2020
2021
Gross Profit
Operating Income
-$51,084,000
-$68,531,000
-$100,734,000
Net Income
-$51,128,000
-$68,800,000
-$101,320,000
2019
Gross Profit
Operating Income
-$51,084,000
Net Income
-$51,128,000
2020
Gross Profit
Operating Income
-$68,531,000
Net Income
-$68,800,000
2021
Gross Profit
Operating Income
-$100,734,000
Net Income
-$101,320,000
The above data on Foghorn Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Adrian Gottschalk
President, Chief Executive Officer and Director
$790,268
$1,834,007
$0
$2,624,275
Adrian Gottschalk
$2,624,275
President, Chief Executive Officer and Director
Carl Decicco
Chief Scientific Officer
$626,240
$542,224
$50,000
$1,218,464
Carl Decicco
$1,218,464
Chief Scientific Officer
Scott Biller
Independent Director
$7,313
$238,859
$0
$246,172
Scott Biller
$246,172
Independent Director
Cigall Kadoch
Director
$7,313
$0
$219,500
$226,813
Cigall Kadoch
$226,813
Director
Douglas Cole
Independent Director
$16,031
$0
$0
$16,031
Douglas Cole
$16,031
Independent Director
Foghorn Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2020. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us